ZEPP Zepp Health Corp Annual reports only
Electronic Computers · NYSE · SEC CIK 1720446 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · USD | FY20242024-12-31 · USD | FY20232023-12-31 · CNY | FY20222022-12-31 · CNY | FY20212021-12-31 · CNY |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $258.90M | $182.60M | 2.50B | 4.14B | 6.25B |
| Cost of revenue | $159.71M | $112.37M | 1.84B | 3.34B | 4.94B |
| Gross profit | $99.19M | $70.23M | 657.78M | 803.12M | 1.31B |
| R&D expense | $45.32M | $46.16M | 361.81M | 517.12M | 515.08M |
| SG&A expense | $29.27M | $24.85M | 188.51M | 235.93M | 258.35M |
| Operating income | -$29.23M | -$47.25M | -207.10M | -410.24M | 93.94M |
| Interest expense | $5.70M | $5.55M | 47.70M | 57.00M | 44.88M |
| Pretax income | -$35.46M | -$57.90M | -236.79M | -372.53M | 106.67M |
| Income tax | $2.54M | $13.69M | -15.82M | -65.88M | 10.74M |
| Net income | -$40.07M | -$75.73M | -212.12M | -288.31M | 137.80M |
| EBITDA | -$24.70M | -$42.23M | -152.65M | -351.62M | 145.83M |
| EPS (basic) | -0.16 | -0.29 | -0.13 | -0.18 | 0.55 |
| EPS (diluted) | -0.16 | -0.29 | -0.13 | -0.18 | 0.52 |
| Weighted avg. shares (diluted) | 254.43M | 258.88M | 243.14M | 246.28M | 264.37M |
| Balance sheet | |||||
| Cash & equivalents | $57.05M | $91.07M | 949.04M | 886.63M | 1.51B |
| Short-term investments | — | $997,000 | 36.59M | 34.32M | 19.35M |
| Receivables | $66.91M | $62.97M | 431.16M | 682.10M | 537.08M |
| Inventory | $72.76M | $56.79M | 602.69M | 1.02B | 1.25B |
| Current assets | $293.52M | $251.56M | 2.25B | 2.96B | 3.93B |
| PP&E, net | $5.66M | $6.90M | 63.40M | 100.61M | 133.87M |
| Goodwill | $9.58M | $9.58M | 68.02M | 66.08M | 61.05M |
| Intangibles | $13.61M | $7.09M | 70.06M | 123.30M | 135.58M |
| Total assets | $564.84M | $528.59M | 4.51B | 5.27B | 6.09B |
| Current liabilities | $286.84M | $195.37M | 1.10B | 1.67B | 2.15B |
| Long-term debt | $59.48M | $75.24M | 852.13M | 684.21M | 726.85M |
| Total debt | $59.48M | $75.24M | 852.13M | 684.21M | 726.85M |
| Total liabilities | $350.30M | $275.87M | 2.01B | 2.58B | 3.15B |
| Shareholders' equity | $214.53M | $251.59M | 2.49B | 2.67B | 2.92B |
| Net debt | $2.43M | -$15.83M | -96.90M | -202.42M | -782.69M |
| Cash flow statement | |||||
| Operating cash flow | -$25.69M | -$24.39M | 298.67M | -787.64M | -232.44M |
| Capital expenditure | $516,000 | $1.40M | 11.30M | 8.14M | 46.05M |
| Free cash flow | -$26.21M | -$25.80M | 287.37M | -795.78M | -278.49M |
| Investing cash flow | $1.48M | -$1.58M | 54.72M | -42.26M | -1.07B |
| Financing cash flow | $24.84M | $477,000 | -295.04M | 289.20M | 551.08M |
| Depreciation & amortization | $4.54M | $5.02M | 54.45M | 58.62M | 51.88M |
| Stock-based compensation | $2.49M | $4.78M | 59.70M | 49.11M | 83.12M |
| Dividends paid | — | — | — | 40.02M | — |
| Share buybacks | $1.24M | $2.28M | 17.77M | 53.22M | 13.76M |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.